Neopterin and Endogenous Interferon Gamma in Serum of Patients with Epstein-Barr Virus-associated Lymphoproliferative Diseases

Pteridines ◽  
1990 ◽  
Vol 2 (3) ◽  
pp. 189-191 ◽  
Author(s):  
Volker Schuster ◽  
Gilbert Reibnegger ◽  
Helmut Wachter
Keyword(s):  
Interferon Gamma ◽  
Epstein Barr Virus ◽  
Lymphoproliferative Diseases ◽  
Barr Virus ◽  
Epstein Barr

EBV+ Lymphoproliferative Diseases: Opportunities for leveraging EBV as a Therapeutic Target

Blood ◽  
2021 ◽  
Author(s):  
Keri Toner ◽  
Catherine M. Bollard
Keyword(s):  
Proliferative Response ◽  
Epstein Barr Virus ◽  
Human Tumor ◽  
Lymphoproliferative Disease ◽  
Lymphoproliferative Diseases ◽  
Malignant Lymphomas ◽  
Barr Virus ◽  
Immune Therapies ◽  
Tumor Virus ◽  
Epstein Barr

Epstein-Barr virus (EBV) is a ubiquitous human tumor virus, which contributes to the development of lymphoproliferative disease, most notably in patients with impaired immunity. EBV associated lymphoproliferation is characterized by expression of latent EBV proteins and ranges in severity from a relatively benign proliferative response to aggressive malignant lymphomas. The presence of EBV can also serve as a unique target for directed therapies for the treatment of EBV lymphoproliferative diseases, including T cell based immune therapies. In this review, we will describe the EBV-associated lymphoproliferative diseases and will particularly focus on the therapies that target EBV.

scholarly journals Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants

2019 ◽  
Vol 7 ◽  
Author(s):  
Masataka Ishimura ◽  
Katsuhide Eguchi ◽  
Akira Shiraishi ◽  
Motoshi Sonoda ◽  
Yoshihiro Azuma ◽  
...  
Keyword(s):  
Epstein Barr Virus ◽  
Gene Variants ◽  
Lymphoproliferative Diseases ◽  
Barr Virus ◽  
Epstein Barr
Sign in / Sign up

Export Citation Format

Share Document